International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Standing Together Fixing the Drug Quality and Security Act

Author(s): Miller David G

Issue: Mar/Apr 2015 - Volume 19, Number 2
View All Articles in Issue

Page(s): 104-106

Standing Together Fixing the Drug Quality and Security Act Page 1

Standing Together Fixing the Drug Quality and Security Act Page 2

Standing Together Fixing the Drug Quality and Security Act Page 3

Download in electronic PDF format for $75

Abstract:

Related Keywords: David G. Miller, RPh, Drug Quality and Security Act, Fix DQSA, section 503A, New England Compounding Center, sterile drug outsourcing facilities, International Academy of Compounding Pharmacists, IACP, U.S. Food and Drug Administration, U.S. FDA, office use, bulk ingredient lists, memorandum of understanding, state laws, state regulations, quality standards, pharmacy inspection

Related Categories: LEGAL, PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Standing Together Fixing the Drug Quality and Security Act Miller David G	Mar/Apr 2015 Pg. 104-106
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Allen Loyd V Jr	Mar/Apr 2018 Pg. 92
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Blankenship Cynthia E	Sep/Oct 2014 Pg. 379-380
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities Miller David G	Mar/Apr 2014 Pg. 117-118
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Miller David G	Jan/Feb 2014 Pg. 35-36
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Miller David G	May/Jun 2014 Pg. 208
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
New England Compounding Center Indictment Cabaleiro Joe	Mar/Apr 2015 Pg. 94-102
Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations McCrory Gary	Mar/Apr 2016 Pg. 95-96
The International Academy of Compounding Pharmacists Introduces a New President Rice Baylor	Mar/Apr 2017 Pg. 116-117
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake	Sep/Oct 2015 Pg. 377-380
The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives Blankenship Cynthia	Jan/Feb 2018 Pg. 26-28
The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871 Rice Baylor	Jul/Aug 2017 Pg. 290-291
Allowing Compounding Pharmacies to Address Drug Shortages Broughel James	Mar/Apr 2022 Pg. 100-109
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Miller David G	Nov/Dec 2012 Pg. 476-478
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Applying Quality of Design Concepts to Pharmacy Compounding Timko Robert J	Nov/Dec 2015 Pg. 453-463
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
Return to Top